PHARMARON BEIJING CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.87 CNY | -0.68% |
|
-2.63% | -34.89% |
| Apr. 08 | Pharmaron Partners Seven Firms to Float 2 Billion Yuan Fund | MT |
| Mar. 28 | Pharmaron's 2023 Profit, Revenue Rise; Misses Estimates | MT |
Chart calendar Pharmaron Beijing Co., Ltd.
3d8beaab43783.TJ9S77kAXeGc0mtwJlUqW-jgPajG9hmfjjOYQZH5dD4.JOZqis9fHqbvoDwmaRsZKL3RdZqWgWrRo36pcfWeNk0VryGOlFAKzPuxMg~fbee9e390ede7af593d5a3f87cf1de13
Upcoming events on Pharmaron Beijing Co., Ltd.
Past events on Pharmaron Beijing Co., Ltd.
| 2024-03-27 10:25 am | Q4 2023 Earnings Release |
| 2023-10-28 | Q3 2023 Earnings Release |
| 2023-09-15 02:30 am | Extraordinary Shareholders Meeting |
| 2023-08-26 | Q2 2023 Earnings Call |
| 2023-08-26 | Q2 2023 Earnings Release |
| 2023-06-21 01:30 am | Annual General Meeting |
| 2023-04-26 | Q1 2023 Earnings Release |
| 2023-03-30 | Q4 2022 Earnings Release |
| 2022-10-26 | Q3 2022 Earnings Release |
| 2022-09-23 02:30 am | Extraordinary Shareholders Meeting |
| 2022-08-28 | Interim 2022 Earnings Release |
| 2022-05-31 02:00 am | Annual General Meeting |
| 2022-04-27 | Q1 2022 Earnings Release |
| 2022-03-27 | FY 2021 Earnings Release |
| 2022-01-14 01:30 am | Extraordinary Shareholders Meeting |
| 2021-10-27 | Q3 2021 Earnings Release |
| 2021-08-29 | Interim 2021 Earnings Release |
| 2021-07-12 02:30 am | Extraordinary Shareholders Meeting |
| 2021-05-28 02:00 am | Annual General Meeting |
| 2021-04-28 | Q1 2021 Earnings Release |
Past dividends on Pharmaron Beijing Co., Ltd.
| 2023-07-26 | Annual 0.3 CNY |
| 2022-06-13 | Annual 0.45 CNY |
| 2021-06-29 | Annual 0.3 CNY |
| 2020-07-14 | Annual 0.15 CNY |
| 2019-07-07 | Annual 0.11 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 3 757 3 765 -0.22% | 5 134 5 121 0.24% | 7 444 7 326 1.6% | 10 266 10 231 0.35% | 11 538 11 629 -0.78% | 12 697 |
|
EBITDA Million CNY | Released Forecast Spread | 951 952 -0.12% | 1 692 1 509 12.1% | 2 399 2 118 13.26% | 2 321 2 618 -11.37% | 2 730 2 953 -7.54% | 3 107 |
|
EBIT Million CNY | Released Forecast Spread | 652 590 10.46% | 875 1 349 -35.16% | 1 914 1 601 19.54% | 1 690 1 893 -10.72% | 1 722 1 897 -9.23% | 1 986 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 633 598 5.83% | 1 319 1 329 -0.72% | 1 911 1 708 11.87% | 1 666 1 871 -10.92% | 1 838 1 883 -2.42% | 1 880 |
|
Net income Million CNY | Released Forecast Spread | 547 518 5.62% | 1 172 1 121 4.56% | 1 661 1 481 12.13% | 1 375 1 584 -13.24% | 1 601 1 626 -1.53% | 1 665 |
|
EPS CNY | Released Forecast Spread | 0,37 0,28 31.93% | 0,66 0,60 9.41% | 0,91 0,83 9.64% | 0,77 0,80 -3.81% | 0,90 0,90 0.49% | 0,95 |
| Announcement Date | 28/02/20 | 28/03/21 | 10/03/22 | 30/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 2 121 2 099 1.04% | 2 193 2 176 0.79% | 2 940 2 977 -1.22% | 3 286 3 220 2.03% | 2 142 2 155 -0.59% | 4 158 4 172 -0.33% | 4 635 4 616 0.4% | 2 863 2 922 -2% | 5 632 5 600 0.57% | 2 724 | 2 916 2 942 -0.87% | 5 640 5 746 -1.84% | 2 920 3 350 -12.82% | 2 978 2 937 1.38% | 5 898 6 107 -3.42% | 2 900 | 3 469 | 6 369 | 3 176 | 3 173 | 6 349 | |
|
EBIT Million CNY | Released Forecast Spread | 531 | 678 655 3.51% | 708 445 59.17% | 1 245 861 44.62% | 760 784 -3.07% | 510 507 0.6% | 415 418 -0.74% | 925 1 074 -13.87% | 432 | 482 474 1.85% | 914 917 -0.37% | 415 563 -26.29% | 424 476 -10.86% | 839 925 -9.27% | 485 | 665 | 1 151 | 447 | 288 | 734 | ||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 640 | 708 583 21.51% | 1 245 1 123 10.87% | 465 591 -21.36% | 459 505 -9.12% | 427 | 482 458 5.22% | 909 885 2.66% | 412 551 -25.15% | 517 558 -7.36% | 929 944 -1.55% | |||||||||||
|
Net income Million CNY | Released Forecast Spread | 521 | 565 550 2.7% | 621 514 20.81% | 1 096 993 10.39% | 376 512 -26.63% | 413 483 -14.39% | 348 | 438 372 17.7% | 786 720 9.18% | 353 446 -20.86% | 462 464 -0.42% | 815 805 1.24% | ||||||||||
|
EPS CNY | Released Forecast Spread | 0,20 | 0,26 0,19 36.74% | 0,27 | |||||||||||||||||||
| Announcement Date | 28/02/20 | 26/08/20 | 28/03/21 | 29/08/21 | 10/03/22 | 10/03/22 | 29/08/22 | 27/10/22 | 30/03/23 | 30/03/23 | 27/04/23 | 27/08/23 | 27/08/23 | 29/10/23 | 27/03/24 | 27/03/24 | - | - | - | - | - | - |
More events
Past sector events for Pharmaron Beijing Co., Ltd.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300759 Stock
- Calendar Pharmaron Beijing Co., Ltd.
